dc.creator | Ferreira-Melo, Silvia Elaine | |
dc.creator | Demacq, Caroline | |
dc.creator | Lacchini, Silvia | |
dc.creator | Krieger, José Eduardo | |
dc.creator | Irigoyen, Maria Cláudia | |
dc.creator | Moreno, Heitor | |
dc.date | 2011 | |
dc.date | 2015-11-27T13:21:50Z | |
dc.date | 2015-11-27T13:21:50Z | |
dc.date.accessioned | 2018-03-29T01:13:49Z | |
dc.date.available | 2018-03-29T01:13:49Z | |
dc.identifier | Clinics (são Paulo, Brazil). v. 66, n. 7, p. 1253-8, 2011. | |
dc.identifier | 1980-5322 | |
dc.identifier | | |
dc.identifier | http://www.ncbi.nlm.nih.gov/pubmed/21876983 | |
dc.identifier | http://repositorio.unicamp.br/jspui/handle/REPOSIP/199611 | |
dc.identifier | 21876983 | |
dc.identifier.uri | http://repositorioslatinoamericanos.uchile.cl/handle/2250/1299844 | |
dc.description | We investigated the influence of sildenafil on cardiac contractility and diastolic relaxation and examined the distribution of phosphodiesterase-5 in the hearts of hypertensive rats that were treated with by NG-nitro-L-arginine methyl ester (L-NAME). Male Wistar rats were treated with L-NAME and/or sildenafil for eight weeks. The Langendorff method was used to examine the effects of sildenafil on cardiac contractility and diastolic relaxation. The presence and location of phosphodiesterase-5 and phosphodiesterase-3 were assessed by immunohistochemistry, and cGMP plasma levels were measured by ELISA. In isolated hearts, sildenafil prevented the reduction of diastolic relaxation (dP/dt) that was induced by L-NAME. In addition, phosphodiesterase-5 immunoreactivity was localized in the intercalated discs between the myocardial cells. The staining intensity was reduced by L-NAME, and sildenafil treatment abolished this reduction. Consistent with these results, the plasma levels of cGMP were decreased in the L-NAME-treated rats but not in rats that were treated with L-NAME + sildenafil. The sildenafil-induced attenuation of the deleterious hemodynamic and cardiac morphological effects of L-NAME in cardiac myocytes is mediated (at least in part) by the inhibition of phosphodiesterase-5. | |
dc.description | 66 | |
dc.description | 1253-8 | |
dc.language | eng | |
dc.relation | Clinics (são Paulo, Brazil) | |
dc.relation | Clinics (Sao Paulo) | |
dc.rights | aberto | |
dc.rights | | |
dc.source | PubMed | |
dc.subject | Animals | |
dc.subject | Arterioles | |
dc.subject | Blood Pressure | |
dc.subject | Cyclic Nucleotide Phosphodiesterases, Type 5 | |
dc.subject | Diastole | |
dc.subject | Enzyme Inhibitors | |
dc.subject | Enzyme-linked Immunosorbent Assay | |
dc.subject | Heart | |
dc.subject | Hypertension | |
dc.subject | Male | |
dc.subject | Myocytes, Cardiac | |
dc.subject | Ng-nitroarginine Methyl Ester | |
dc.subject | Phosphodiesterase 5 Inhibitors | |
dc.subject | Piperazines | |
dc.subject | Purines | |
dc.subject | Rats | |
dc.subject | Rats, Wistar | |
dc.subject | Sulfones | |
dc.subject | Time Factors | |
dc.title | Sildenafil Preserves Diastolic Relaxation After Reduction By L-name And Increases Phosphodiesterase-5 In The Intercalated Discs Of Cardiac Myocytes And Arterioles. | |
dc.type | Artículos de revistas | |